# FDA Inspection 1265717 - CSL Plasma Inc. - March 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/5c8139fc-76fa-4d19-b7e3-ad52e6223bd7
Source feed: FDA_Inspections

> FDA Inspection 1265717 for CSL Plasma Inc. on March 27, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265717
- Company Name: CSL Plasma Inc.
- Inspection Date: 2025-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265717 - 2025-03-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/202bdef3-8213-479c-a45b-3d0cb0657660)
- [FDA Inspection 1088649 - 2019-05-02](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/f7b789c9-ab07-4203-a950-74bfaf1eebe6)
- [FDA Inspection 1069524 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/8fdfcdad-c603-47d2-b45b-53da1717dfb9)

Company: https://www.keypedia.com/companies/csl-plasma-inc/e24fce70-7c46-4cae-934e-4e4d4f4c76d9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d